Mannatech GAAP EPS of $4.61, revenue of $24.87M
Mannatech reported Q3 GAAP earnings per share of $4.61 and revenue of $24.87M, down 14.8% year-over-year, according to a press release.
How this was made
The 30-second read
Why it matters
The earnings release provides the first public disclosure of Q3 results, introducing new data to the market.
Market read
First report of Q3 earnings for a micro‑cap; may cause short‑term price movement.
What to watch
Potential cost reductions or upcoming product launches not disclosed in the release.
Background
Mannatech is a small-cap company focused on nutritional supplements.
Ticker impact
Mannatech reported Q3 GAAP EPS of $4.61 and revenue of $24.87M, a 14.8% YoY decline.
likely downside as the market prices in the revenue decline
The company posted a significant revenue drop despite a positive EPS, which typically pressures the stock in the short term.
Market effects
May weigh on the dietary supplement sector if the decline signals broader demand weakness.
Limited to U.S. over‑the‑counter health product market.
Minimal global impact given the company's small size.
Counterpoint
If the EPS beat expectations, the stock could rebound despite revenue decline.
Key entities
- CompanyMannatech, Inc.
Issuer of the earnings report.
